Unknown

Dataset Information

0

Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.


ABSTRACT: Significant progress has been made over the past decade in haploidentical transplantation, with the development of novel methods to control intense alloreactive reactions generated in the major HLA-mismatched setting. Application of post-transplantation cyclophosphamide has gained worldwide acceptance as an effective and low-cost way to perform this type of transplantation, with outcomes now similar to those from HLA-matched unrelated donors. These advances have resulted in improved treatment-related mortality, whereas disease relapse has emerged as the most common cause of treatment failure. In addition, improvements in immunologic reconstitution after transplantation are much needed, not only in haploidentical transplantation but in all forms of stem cell transplantation. This symposium has focused on some of the most promising methods to control alloreactivity in this form of transplantation and application of cellular therapy to prevent disease relapse after transplantation, as well as understanding immunologic reconstitution and foreseeable approaches to improve immune recovery after transplantation.

SUBMITTER: Al Malki MM 

PROVIDER: S-EPMC7104805 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.

Al Malki Monzr M MM   Horowitz Mary M   Handgretinger Rupert R   Leung Wing W   Roy Denis-Claude DC   Huang Xiao-Jun XJ   Fuchs Ephraim E   Locatelli Franco F   Blaise Didier D   Mineishi Shin S   Martelli Massimo M   Miller Jeffrey J   June Carl C   Ai Hui-Sheng HS   Luznik Leo L   Mavilio Domenico D   Lugli Enrico E   van den Brink Marcel R M MRM   Champlin Richard E RE   Ciurea Stefan O SO  

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20160113 4


Significant progress has been made over the past decade in haploidentical transplantation, with the development of novel methods to control intense alloreactive reactions generated in the major HLA-mismatched setting. Application of post-transplantation cyclophosphamide has gained worldwide acceptance as an effective and low-cost way to perform this type of transplantation, with outcomes now similar to those from HLA-matched unrelated donors. These advances have resulted in improved treatment-re  ...[more]

Similar Datasets

| S-EPMC7187910 | biostudies-literature
| S-EPMC10686190 | biostudies-literature
| S-EPMC9748624 | biostudies-literature
| EGAO00000001152 | EGA
| S-EPMC9152783 | biostudies-literature
| S-EPMC3380792 | biostudies-literature
| S-EPMC7042248 | biostudies-literature
| S-EPMC9441075 | biostudies-literature